Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Eukedos SpALTS:0Q8E 32 EBITDA Margin % is 22.41% as of Dec. 2025, which is 9% above its 10-year median of 20.49. GuruFocus rates LTS:0Q8E with a GF Score™ of 32/100 and a GF Value™ of €2.60. The stock has 7 warning signs investors should review. Among 664 Healthcare Providers & Services companies, Eukedos SpA ranks better than 78.61% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Eukedos SpA's EBITDA for the
six
months ended in Dec. 2025 was €6.08 Mil. Eukedos SpA's Revenue for the
six
months ended in Dec. 2025 was €27.12 Mil. Therefore, Eukedos SpA's EBITDA margin for the quarter that ended in Dec. 2025 was 22.41%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Eukedos SpA EBITDA Margin % Related Terms
Eukedos SpA EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Eukedos SpA's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LTS:0Q8E vs HCA, THC, DVA: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, Eukedos SpA's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Eukedos SpA EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Eukedos SpA's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Eukedos SpA's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Eukedos SpA (LTS:0Q8E) has a EBITDA Margin % of 22.41% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Eukedos SpA and its competitors. This is near median its historical median of 20.49. Over the past decade, Eukedos SpA's EBITDA Margin % has ranged from 1.51 to 25.09. According to the industry distribution chart, Eukedos SpA ranks #142 out of 664 companies in the Healthcare Providers & Services industry, placing it in the top 21.4%.
Is Eukedos SpA's EBITDA Margin % too high?
Eukedos SpA's current EBITDA Margin % of 22.41% is near median its 10-year median of 20.49. Over the past 10 years, this metric has ranged from a low of 1.51 to a high of 25.09. The Healthcare Providers & Services industry median EBITDA Margin % is 10.21. Eukedos SpA's value of 22.41% is 119.5% above this industry median. Based on the distribution chart, Eukedos SpA ranks #142 out of 664 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Eukedos SpA has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Eukedos SpA's EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Eukedos SpA ranks #142 out of 664 companies for EBITDA Margin %. This places Eukedos SpA in the top 21% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 10.21. Eukedos SpA's value of 22.41% is 119.5% above this benchmark. Historically, Eukedos SpA's own EBITDA Margin % has ranged from 1.51 to 25.09 over the past decade. While the company's 10-year median is 20.49 vs. the industry median of 10.21, Eukedos SpA has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 664 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Eukedos SpA's current EBITDA Margin % of 22.41% is 119.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Eukedos SpA and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Eukedos SpA's current EBITDA Margin % is 22.41%, which is near median its own 10-year median of 20.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eukedos SpA stock overvalued right now?
Eukedos SpA (LTS:0Q8E) has a current EBITDA Margin % of 22.41%. The stock's GF Value™ is €2.60, compared to a current price of €1.77 — trading 31.9% below its estimated fair value. The current EBITDA Margin % is 22.41%, which is near median its 10-year median of 20.49 and 119.5% above the Healthcare Providers & Services industry median of 10.21. Eukedos SpA's overall GF Score™ is 32/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Eukedos SpA (LTS:0Q8E), the current EBITDA Margin % is 22.41% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Eukedos SpA (LTS:0Q8E) Overvalued in 2026?
Based on GuruFocus' analysis, Eukedos SpA stock appears to be undervalued.
The current stock price of €1.77 is trading 31.9% below its estimated GF Value™ of €2.60.
Key valuation signals for LTS:0Q8E:
EBITDA Margin %: 22.41% (near median its 10-year median of 20.49)
GF Value™: €2.60 vs. price of €1.77 (31.9% below fair value)
Industry Position: 119.5% above the Healthcare Providers & Services median (#142 of 664)
No single metric tells the full story. See the LTS:0Q8E stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0Q8E has been successfully added to your 
